Literature DB >> 14984244

Direct measurement of alcohol and its metabolites.

Robert Swift1.   

Abstract

BACKGROUND: Ethanol can be easily and accurately measured in body fluids or vapours by several chemical and enzymatic methods. However, the persistence of ethanol in the body is short lived and ethanol's metabolism and distribution within the body are extremely complex. AIM: This article discusses the complex pharmacokinetics of ethanol and how pharmacokinetics can affect measured ethanol concentrations when ethanol is sampled across different individuals or from different body fluids or vapors, such as whole blood, plasma, breath, urine, saliva, or transdermal ethanol.
FINDINGS: Several physical methods for the quantification of ethanol concentrations are described, including gas chromatography, electrochemical detection, infrared detection and enzymatic methods, along with their advantages and limitations. Also discussed, is the utility of the measurement of several immediate metabolites of ethanol, including acetaldehyde. acetate, and fatty acid ethyl esters.
CONCLUSIONS: The complex distribution and metabolism of ethanol and its metabolites can obscure the relationship between the ethanol concentration that is measured in body fluids or vapours and the amount of ethanol that is actually taken into the body.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14984244     DOI: 10.1046/j.1359-6357.2003.00605.x

Source DB:  PubMed          Journal:  Addiction        ISSN: 0965-2140            Impact factor:   6.526


  62 in total

1.  Sensitivity and specificity of urinary ethyl glucuronide and ethyl sulfate in liver disease patients.

Authors:  Scott H Stewart; David G Koch; Douglas M Burgess; Ira R Willner; Adrian Reuben
Journal:  Alcohol Clin Exp Res       Date:  2012-06-22       Impact factor: 3.455

2.  Estimating BrAC from transdermal alcohol concentration data using the BrAC estimator software program.

Authors:  Susan E Luczak; I Gary Rosen
Journal:  Alcohol Clin Exp Res       Date:  2014-08       Impact factor: 3.455

3.  Using contingency management procedures to reduce at-risk drinking in heavy drinkers.

Authors:  Donald M Dougherty; Sarah L Lake; Nathalie Hill-Kapturczak; Yuanyuan Liang; Tara E Karns; Jillian Mullen; John D Roache
Journal:  Alcohol Clin Exp Res       Date:  2015-04       Impact factor: 3.455

Review 4.  The use of salivary biomarkers in occupational and environmental medicine.

Authors:  David Soo-Quee Koh; Gerald Choon-Huat Koh
Journal:  Occup Environ Med       Date:  2007-03       Impact factor: 4.402

Review 5.  Proteomic approaches and identification of novel therapeutic targets for alcoholism.

Authors:  Giorgio Gorini; R Adron Harris; R Dayne Mayfield
Journal:  Neuropsychopharmacology       Date:  2013-07-31       Impact factor: 7.853

6.  Use of continuous transdermal alcohol monitoring during a contingency management procedure to reduce excessive alcohol use.

Authors:  Donald M Dougherty; Nathalie Hill-Kapturczak; Yuanyuan Liang; Tara E Karns; Sharon E Cates; Sarah L Lake; Jillian Mullen; John D Roache
Journal:  Drug Alcohol Depend       Date:  2014-07-11       Impact factor: 4.492

Review 7.  Ethanol consumption: how should we measure it? Achieving consilience between human and animal phenotypes.

Authors:  Robert F Leeman; Markus Heilig; Christopher L Cunningham; David N Stephens; Theodora Duka; Stephanie S O'Malley
Journal:  Addict Biol       Date:  2010-04       Impact factor: 4.280

Review 8.  Assessment of Alcohol Use in the Natural Environment.

Authors:  Thomas M Piasecki
Journal:  Alcohol Clin Exp Res       Date:  2019-03-01       Impact factor: 3.455

9.  Experiences with SCRAMx alcohol monitoring technology in 100 alcohol treatment outpatients.

Authors:  Sheila M Alessi; Nancy P Barnett; Nancy M Petry
Journal:  Drug Alcohol Depend       Date:  2017-06-28       Impact factor: 4.492

10.  Real-time assessment of alcohol drinking and drug use in opioid-dependent polydrug users.

Authors:  Kenzie L Preston; Michelle L Jobes; Karran A Phillips; David H Epstein
Journal:  Behav Pharmacol       Date:  2016-10       Impact factor: 2.293

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.